250 related articles for article (PubMed ID: 32039571)
21. Establishment and Characterisation by Expression Microarray of Patient-Derived Xenograft Panel of Human Pancreatic Adenocarcinoma Patients.
Roche S; O'Neill F; Murphy J; Swan N; Meiller J; Conlon NT; Geoghegan J; Conlon K; McDermott R; Rahman R; Toomey S; Straubinger NL; Straubinger RM; O'Connor R; McVey G; Moriarty M; Clynes M
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32024004
[TBL] [Abstract][Full Text] [Related]
22. Macrophages potentiate STAT3 signaling in skeletal muscles and regulate pancreatic cancer cachexia.
Shukla SK; Markov SD; Attri KS; Vernucci E; King RJ; Dasgupta A; Grandgenett PM; Hollingsworth MA; Singh PK; Yu F; Mehla K
Cancer Lett; 2020 Aug; 484():29-39. PubMed ID: 32344015
[TBL] [Abstract][Full Text] [Related]
23. Molecular and Physiological Evaluation of Pancreatic Cancer-Induced Cachexia.
Shukla SK; Dasgupta A; Mulder SE; Singh PK
Methods Mol Biol; 2019; 1882():321-333. PubMed ID: 30378066
[TBL] [Abstract][Full Text] [Related]
24. Muscle weakness and mitochondrial stress occur before metastasis in a novel mouse model of ovarian cancer cachexia.
Delfinis LJ; Ogilvie LM; Khajehzadehshoushtar S; Gandhi S; Garibotti MC; Thuhan AK; Matuszewska K; Pereira M; Jones RG; Cheng AJ; Hawke TJ; Greene NP; Murach KA; Simpson JA; Petrik J; Perry CGR
bioRxiv; 2024 Apr; ():. PubMed ID: 38645227
[TBL] [Abstract][Full Text] [Related]
25. Circulating myeloid cells invade the central nervous system to mediate cachexia during pancreatic cancer.
Burfeind KG; Zhu X; Norgard MA; Levasseur PR; Huisman C; Buenafe AC; Olson B; Michaelis KA; Torres ER; Jeng S; McWeeney S; Raber J; Marks DL
Elife; 2020 May; 9():. PubMed ID: 32391790
[TBL] [Abstract][Full Text] [Related]
26. Selumetinib Attenuates Skeletal Muscle Wasting in Murine Cachexia Model through ERK Inhibition and AKT Activation.
Quan-Jun Y; Yan H; Yong-Long H; Li-Li W; Jie L; Jin-Lu H; Jin L; Peng-Guo C; Run G; Cheng G
Mol Cancer Ther; 2017 Feb; 16(2):334-343. PubMed ID: 27599525
[TBL] [Abstract][Full Text] [Related]
27. Tumour-derived leukaemia inhibitory factor is a major driver of cancer cachexia and morbidity in C26 tumour-bearing mice.
Kandarian SC; Nosacka RL; Delitto AE; Judge AR; Judge SM; Ganey JD; Moreira JD; Jackman RW
J Cachexia Sarcopenia Muscle; 2018 Dec; 9(6):1109-1120. PubMed ID: 30270531
[TBL] [Abstract][Full Text] [Related]
28. Orthotopic model of human pancreatic ductal adenocarcinoma and cancer cachexia in nude mice.
Jones-Bolin S; Ruggeri B
Curr Protoc Pharmacol; 2007 Jun; Chapter 14():Unit 14.3. PubMed ID: 21948162
[TBL] [Abstract][Full Text] [Related]
29. Valproic acid attenuates skeletal muscle wasting by inhibiting C/EBPβ-regulated atrogin1 expression in cancer cachexia.
Sun R; Zhang S; Hu W; Lu X; Lou N; Yang Z; Chen S; Zhang X; Yang H
Am J Physiol Cell Physiol; 2016 Jul; 311(1):C101-15. PubMed ID: 27122162
[TBL] [Abstract][Full Text] [Related]
30. Brain metabolites in cholinergic and glutamatergic pathways are altered by pancreatic cancer cachexia.
Winnard PT; Bharti SK; Sharma RK; Krishnamachary B; Mironchik Y; Penet MF; Goggins MG; Maitra A; Kamel I; Horton KM; Jacobs MA; Bhujwalla ZM
J Cachexia Sarcopenia Muscle; 2020 Dec; 11(6):1487-1500. PubMed ID: 33006443
[TBL] [Abstract][Full Text] [Related]
31. Role of PARP activity in lung cancer-induced cachexia: Effects on muscle oxidative stress, proteolysis, anabolic markers, and phenotype.
Chacon-Cabrera A; Mateu-Jimenez M; Langohr K; Fermoselle C; García-Arumí E; Andreu AL; Yelamos J; Barreiro E
J Cell Physiol; 2017 Dec; 232(12):3744-3761. PubMed ID: 28177129
[TBL] [Abstract][Full Text] [Related]
32. Antibody-directed myostatin inhibition enhances muscle mass and function in tumor-bearing mice.
Murphy KT; Chee A; Gleeson BG; Naim T; Swiderski K; Koopman R; Lynch GS
Am J Physiol Regul Integr Comp Physiol; 2011 Sep; 301(3):R716-26. PubMed ID: 21677277
[TBL] [Abstract][Full Text] [Related]
33. Physiologic and molecular characterization of a novel murine model of metastatic head and neck cancer cachexia.
Olson B; Norgard MA; Levasseur PR; Zhu X; Marks DL
J Cachexia Sarcopenia Muscle; 2021 Oct; 12(5):1312-1332. PubMed ID: 34231343
[TBL] [Abstract][Full Text] [Related]
34. Treating cachexia using soluble ACVR2B improves survival, alters mTOR localization, and attenuates liver and spleen responses.
Nissinen TA; Hentilä J; Penna F; Lampinen A; Lautaoja JH; Fachada V; Holopainen T; Ritvos O; Kivelä R; Hulmi JJ
J Cachexia Sarcopenia Muscle; 2018 Jun; 9(3):514-529. PubMed ID: 29722201
[TBL] [Abstract][Full Text] [Related]
35. Detection of Pancreatic Cancer-Induced Cachexia Using a Fluorescent Myoblast Reporter System and Analysis of Metabolite Abundance.
Winnard PT; Bharti SK; Penet MF; Marik R; Mironchik Y; Wildes F; Maitra A; Bhujwalla ZM
Cancer Res; 2016 Mar; 76(6):1441-50. PubMed ID: 26719527
[TBL] [Abstract][Full Text] [Related]
36. Orthotopic Patient-Derived Pancreatic Cancer Xenografts Engraft Into the Pancreatic Parenchyma, Metastasize, and Induce Muscle Wasting to Recapitulate the Human Disease.
Go KL; Delitto D; Judge SM; Gerber MH; George TJ; Behrns KE; Hughes SJ; Judge AR; Trevino JG
Pancreas; 2017 Jul; 46(6):813-819. PubMed ID: 28609371
[TBL] [Abstract][Full Text] [Related]
37. Osteopenia is associated with wasting in pancreatic adenocarcinoma and predicts survival after surgery.
Cameron ME; Underwood PW; Williams IE; George TJ; Judge SM; Yarrow JF; Trevino JG; Judge AR
Cancer Med; 2022 Jan; 11(1):50-60. PubMed ID: 34791809
[TBL] [Abstract][Full Text] [Related]
38. Mas Receptor Activation Slows Tumor Growth and Attenuates Muscle Wasting in Cancer.
Murphy KT; Hossain MI; Swiderski K; Chee A; Naim T; Trieu J; Haynes V; Read SJ; Stapleton DI; Judge SM; Trevino JG; Judge AR; Lynch GS
Cancer Res; 2019 Feb; 79(4):706-719. PubMed ID: 30420474
[TBL] [Abstract][Full Text] [Related]
39. Profiling of Adipose and Skeletal Muscle in Human Pancreatic Cancer Cachexia Reveals Distinct Gene Profiles with Convergent Pathways.
Narasimhan A; Zhong X; Au EP; Ceppa EP; Nakeeb A; House MG; Zyromski NJ; Schmidt CM; Schloss KNH; Schloss DEI; Liu Y; Jiang G; Hancock BA; Radovich M; Kays JK; Shahda S; Couch ME; Koniaris LG; Zimmers TA
Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33923976
[TBL] [Abstract][Full Text] [Related]
40. Pancreatic cancer cell-derived IGFBP-3 contributes to muscle wasting.
Huang XY; Huang ZL; Yang JH; Xu YH; Sun JS; Zheng Q; Wei C; Song W; Yuan Z
J Exp Clin Cancer Res; 2016 Mar; 35():46. PubMed ID: 26975989
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
